T. Plech, “The impact of ACE inhibitors on the risk of SARS-CoV-2 virus infection and the course of COVID-19 disease”, Pol J Public Health, vol. 129, no. 4, pp. 148–151, Sep. 2020, doi: 10.2478/pjph-2019-0034.